VNRX-5133

VenatoRx initiates enrollment in phase 3 trial of cefepime/VNRX-5133 in cUTIs
Pharmaceutical Business Review
Fri, 08/30/19 - 01:05 pm
VenatoRx
clinical trials
UTIs
complicated urinary tract infections
cefepime
VNRX-5133